Funahashi Yasuhito, Wang Zhou, O'Malley Katherine J, Tyagi Pradeep, DeFranco Donald B, Gingrich Jeffrey R, Takahashi Ryosuke, Majima Tsuyoshi, Gotoh Momokazu, Yoshimura Naoki
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Prostate. 2015 Mar 1;75(4):381-9. doi: 10.1002/pros.22924. Epub 2014 Nov 28.
Prostatic inflammation is reportedly associated with the development of prostatic hyperplasia. We investigated the effects of prostatic inflammation on expression levels of androgen-responsive genes and growth factors in the rat prostate.
Prostatic inflammation was induced by Escherichia coli (strain 1677) injection (0.2 ml of 1 × 10(8) CFU/ml) into the prostatic urethra of male Sprague-Dawley rats, and ventral lobes of the prostate were harvested on day 84. Rats were given 10 mg/kg celecoxib during the last month in the COX-2 inhibitor treated group. Histopathology and multiplex enzyme-linked immunosorbent assay (ELISA) for inflammation-related proteins were performed. Glandular epithelial cells and stromal regions were separately isolated using laser-capture microdissection (LCM). Real-time RT-PCR was performed to examine mRNA levels of androgen-responsive genes in the epithelium and tumor growth factor-β1 (TGF-β1) cascade genes in the stroma.
Hematoxylin and eosin staining showed that mild inflammation was distributed diffusely throughout the prostate. Polymorphonuclear cells infiltrated the slightly edematous stroma, but no morphological changes were observed in the epithelium. Immunohistochemically, expression of androgen receptor and TGF-β1 in addition to IL-6 and cyclooxigenase-2 (COX-2) were enhanced in the E. coli inoculated rats. All of these factors were suppressed in the celecoxib-treated rats. Upregulation of IL-1α, IL-1β, IL-6, and RANTES in the E. coli-inoculated rats was normalized by celecoxib treatment. Significant upregulation of androgen receptor and androgen-responsive genes such as Eaf2, ELL2, FKBP5, calreticulin, and ornithine decarboxylase was observed in the LCM-dissected epithelium. Also TGF-β1 and its downstream cascade genes such as Hic-5, collagen 1, and fibronectin were upregulated significantly in the LCM-dissected stroma. The COX-2 inhibitor treatment suppressed upregulation of these genes.
Prostatic inflammation changed the expression of androgen-responsive genes in the epithelium and TGF-β1 cascade genes in the stroma. Activation of TGF-β1 cascade genes in the inflamed stroma, as well as altered androgen-responsive gene expression in the epithelium, might be involved in the development of BPH. Prostate 75:381-389, 2015. © 2014 Wiley Periodicals, Inc.
据报道,前列腺炎症与前列腺增生的发生有关。我们研究了前列腺炎症对大鼠前列腺中雄激素反应性基因和生长因子表达水平的影响。
通过向雄性Sprague-Dawley大鼠的前列腺尿道注射大肠杆菌(1677株,0.2 ml,1×10⁸ CFU/ml)诱导前列腺炎症,并在第84天采集前列腺腹叶。在COX-2抑制剂治疗组的最后一个月,给大鼠给予10 mg/kg塞来昔布。进行了组织病理学检查和炎症相关蛋白的多重酶联免疫吸附测定(ELISA)。使用激光捕获显微切割(LCM)分别分离腺上皮细胞和基质区域。进行实时RT-PCR以检测上皮中雄激素反应性基因的mRNA水平和基质中肿瘤生长因子-β1(TGF-β1)级联基因的mRNA水平。
苏木精和伊红染色显示轻度炎症弥漫分布于整个前列腺。多形核细胞浸润轻度水肿的基质,但上皮未观察到形态学变化。免疫组织化学显示,在接种大肠杆菌的大鼠中,雄激素受体、TGF-β1以及IL-6和环氧化酶-2(COX-2)的表达增强。在塞来昔布治疗的大鼠中,所有这些因子均受到抑制。塞来昔布治疗使接种大肠杆菌的大鼠中IL-1α、IL-1β、IL-6和RANTES的上调恢复正常。在LCM分离的上皮中观察到雄激素受体和雄激素反应性基因如Eaf2、ELL2、FKBP5、钙网蛋白和鸟氨酸脱羧酶的显著上调。在LCM分离的基质中,TGF-β1及其下游级联基因如Hic-5、胶原蛋白1和纤连蛋白也显著上调。COX-2抑制剂治疗抑制了这些基因的上调。
前列腺炎症改变了上皮中雄激素反应性基因和基质中TGF-β1级联基因的表达。炎症基质中TGF-β1级联基因的激活以及上皮中雄激素反应性基因表达的改变可能参与了良性前列腺增生的发生。前列腺75:381-389,2015。©2014威利期刊公司。